Main Menu

Akoya Biosciences, Inc.

(NASDAQ GS: AKYA)

Rigrodsky Law, P.A. is investigating Akoya Biosciences, Inc. (“Akoya”) regarding possible breaches of fiduciary duties and other violations of law related to Akoya’s agreement to be acquired by Quanterix Corporation (“Quanterix”). Under the terms of the agreement, Akoya shareholders will receive 0.318 shares of Quanterix common stock for each share of Akoya common stock owned.

Join This Action

Alternatively, you may upload your transactions using the upload button below or email them to info@rl-legal.com.

Draw your signature below using your mouse* [Clear]

Signed pursuant to California Civil Code Section 1633.1, et seq. - and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.

Date of signing: 01/20/2025


* Indicates a required field.

Back to Page